HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Mottram Selected Research

Ascites

6/2005Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
1/2005CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
8/2004Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Mottram Research Topics

Disease

7Neoplasms (Cancer)
09/2007 - 05/2003
3Ascites
06/2005 - 08/2004
2Ovarian Neoplasms (Ovarian Cancer)
04/2006 - 01/2005
1Hepatocellular Carcinoma (Hepatoma)
03/2021
1Leukocytosis (Pleocytosis)
08/2009
1Starvation
01/2005
1Hypoxia (Hypoxemia)
01/2005
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2004
1Autoimmune Diseases (Autoimmune Disease)
11/2004

Drug/Important Bio-Agent (IBA)

4AntigensIBA
09/2007 - 09/2004
2Interleukin-6 (Interleukin 6)IBA
08/2009 - 09/2007
2Interleukin-8 (Interleukin 8)IBA
08/2009 - 08/2004
2Interleukin-10 (Interleukin 10)IBA
09/2007 - 06/2005
2Chemokine CCL22IBA
09/2007 - 09/2004
2InterleukinsIBA
09/2007 - 06/2005
1ParaffinIBA
03/2021
1CytokinesIBA
04/2006
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2006
1ArginaseIBA
04/2006
1Chemokine CCL19IBA
06/2005
1ChemokinesIBA
06/2005
1matrigelIBA
01/2005
1CXC ChemokinesIBA
01/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2005
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2004

Therapy/Procedure

1Immunotherapy
05/2003